About QIAGEN (Suzhou) Translational Medicine Co
QIAGEN (Suzhou) Translational Medicine Co. (TMC) Ltd. is the first diagnostic R&D company focused on translational science in China. The company provides complete solutions for precision medicine through translational science. Jointly established by QIAGEN and China SIP Biotechnology Development Co. Ltd., QIAGEN (Suzhou) TMC’s mission is the development and validation of biomarkers and companion diagnostics as well as patient stratification for clinical trials.
State of Ownership
Sales Account Executive, Springer Nature
Product Manager, Nature Publishing Group
CEO & Co-Founder, Zapnito
Chief Product Officer, Zapnito
Former Head of Communities, Springer Nature